HIV-infected adults have heightened monocyte activation and inflammation, at least partially as a consequence of altered gut integrity. The role of dietary factors in microbial translocation and inflammation and their downstream effect on markers of cardiovascular disease (CVD) have not been explored. Our purpose was to describe the longitudinal dietary patterns of HIV-infected adults, and to examine the relationship between dietary intake, gut integrity, inflammation and subclinical markers of CVD in HIV-infected adults.
Introduction
In this era of effective HIV treatment, HIV-infected adults experience marked increases in chronic comorbid conditions such as cardiovascular disease (CVD), kidney disease, and cancers. One of the most prevalent chronic conditions in this population is CVD, which HIV-infected adults are at approximately two-fold higher risk of developing. [1, 2] Lifestyle behaviours including diet, exercise and smoking have long been linked to CVD and are increasingly being examined in adults living with HIV. [3] [4] [5] [6] Different mechanisms have been proposed linking lifestyle behaviours to chronic diseases; for example, increased vascular health has been linked to decreased inflammation. [4] The role of lifestyle behaviours, particularly diet, in gut integrity and immune activation and subsequently in cardiovascular health has not yet been explored in this population, and may help to define a direct pathway between diet and increased CVD in people living with HIV.
With the rapid increase in the scale-up of antiretroviral therapy (ART) at the end of the 20th Century, several investigators examined the role of dietary intake in metabolic abnormalities in HIV-infected adults on ART. This work focused on two key dietary components, fat and fibre, and suggested that decreased fat consumption and increased fibre consumption lead to improved insulin resistance and decreased hyperlipidaemia in HIV-infected adults; [7, 8] and more recent work has reported similar results [9, 10] . Yet, the sample sizes in these studies were small and the populations homogenous, and these studies had short follow-up. [10] A longer term study with a diverse sample in the current HIV era will help us to understand the relationship between dietary composition, immune activation and cardiovascular health in this population.
HIV-infected individuals also experience significant damage to the gut-associated lymphoid tissues, with increases in inflammation leading to decreased Toll-like receptor 4 (TLR4) expression and T helper cell 17 (TH17) availability and a loss of enterocytes and tight junctions. [11] Bacterial products, such as lipopolysaccharide (LPS), can more easily translocate into the bloodstream, interact with LPS-binding protein (LBP), and induce chronic systemic immune activation in HIV-infected adults [12] [13] [14] . Metabolic conditions, including diabetes and obesity, are also characterized by increased inflammation. A possible link between diet, inflammation and metabolic complications is the gut microbiota. This microbiota has many roles, including assisting with immunity and metabolism. Disruption of this microbiota (dysbiosis) has been associated with a number of chronic diseases including irritable bowel syndrome, obesity and type 2 diabetes [15] .Diet can quickly change the gut microbiota, with high-fat diets raising serum LPS and LBP levels and leading to increased inflammation and weight gain. [16] Further, fibre can improve gut microbiota by increasing the production of short-chain fatty acids, leading to immune regulation. [17] Finally, alcohol has also been shown to increase serum LPS levels, increasing inflammation. [18] Given the inflammatory milieu associated with HIV infection, it is possible that a poor diet may exacerbate inflammation in HIV-infected adults, thereby contributing to the excess cardiovascular disease in this population.
Before exploring this hypothesis, we need to understand the composition of the typical HIV-infected adult diet intake in the current HIV era. While, historically, nutrition counselling for HIV-infected patients has focused on preventing HIV-associated wasting, today's dietary recommendations focus on preventing metabolic disease. Although not based on any current or HIVspecific data, low carbohydrate, well-balanced diets, with little alcohol consumption, are common recommendations. [19] [20] [21] [22] [23] Though there are sound data describing the relationship of food security to nutritional status in HIVinfected adults, typically in low-and middle-income settings, [24] we lack longitudinal evidence describing the dietary patterns of HIV-infected adults in a high-resource setting and in the contemporary HIV treatment era.
Therefore, the purpose of our study was two-fold: (1) to describe the longitudinal dietary patterns of HIVinfected treated adults in a contemporary, high-resource setting; and (2) to examine the relationship between dietary intake, gut integrity, inflammation and subclinical markers of CVD in HIV-infected adults. We hypothesized that higher dietary intake of fat and alcohol would be related to worse gut integrity [increased intestinal fatty acid-binding protein (I-FABP) and LBP, and decreased zonulin-1], increased monocyte activation [increased proportions of pro-inflammatory monocytes CD14(Dim)CD16(+) and CD14+CD16+ monocytes, and soluble markers sCD14 and sCD163], inflammation [increased interleukin (IL)-6, soluble tumour necrosis factor receptor II (sTNFR-II) and vascular cell adhesion protein (VCAM)] and worse markers of subclinical CVD [increased carotid intima-media thickness (CIMT) and coronary calcification (CAC)].
Materials and methods

Study design
We conducted an analysis of 147 HIV-infected subjects followed for 96 weeks in the Stopping Atherosclerosis and Treating Unhealthy Bone With Rosuvastatin in HIV (SATURN-HIV) study, a placebo-controlled randomized clinical trial testing the effect of rosuvastatin on markers of CVD and bone disease, to assess the effects of dietary intake on gut integrity and inflammation.
Study subjects
All participants were HIV-infected, were ≥ 18 years of age, and had been on stable HIV ART for at least 3 months. All had HIV RNA < 1000 HIV-1 RNA copies/ ml, fasting low-density lipoprotein (LDL) cholesterol ≤ 130 mg/dl and triglycerides ≤ 500 mg/dl. Additionally, participants either had evidence of heightened T-cell activation, identified as a proportion of activated CD8 T cells of ≥ 19%, or had levels of high-sensitivity C-reactive protein (hsCRP) ≥ 2 mg/L. Participants were excluded if they had a history of coronary disease or diabetes, were pregnant or lactating, or had an active infectious or inflammatory condition. All study procedures were approved by the Institutional Review Board of University Hospitals Case Medical Center, Cleveland, Ohio, USA.
Study procedures
Potential subjects were recruited, via an Institutional Review Board (IRB)-approved flyer, from HIV clinics and AIDS service organizations in northeast Ohio. Interested subjects were scheduled for a screening visit at which study staff explained study procedures and obtained informed written consent. At this visit, eligibility was confirmed with a fasting blood draw and through evaluation of medical records. If the subjects met the eligibility criteria, they were randomized 1:1 to rosuvastatin 10 mg daily vs matching placebo.
Dietary assessment
At study entry, subjects completed a self-reported demographic and substance use questionnaire. At study entry, 24, 48 and 96 weeks post randomization subjects also completed a standardized food interview, the Block Alive Screener by Nutrition Quest, Berkeley, CA, USA. A research assistant read the questions to all participants, at all timepoints, to ensure that they understood and completed each question. This dietary assessment tool contains 55 questions and asks participants to report both the frequency and quantity of food intake based on "eating habits over the past year or so." Portion size was asked about for 32 food items and a series of 15 additional questions asked about usual intake of low-fat/trans-fat-free or low-carbohydrate/low-sugar versions of various foods. Responses to these 15 questions were used to fine-tune estimates of fat, sugar and dietary fibre; values for these adjustments were developed from National Health and Nutrition Examination Survey (NHANES) 1999À2002 dietary recall data [25] . Nutrient estimates were calculated by multiplying frequency, portion size and nutrient content and summing over all foods. Four-month testÀretest reliability (reproducibility) of the dietary questionnaire ranged from 0.66 to 0.78, indicating good reliability. [26, 27] This dietary interview takes approximately 10 min to complete. Additionally, alcohol use was assessed with four survey questions. Subjects were asked at each visit whether they currently consumed alcohol. If subjects responded affirmatively, they were prompted to note: (1) how many servings of beer, (2) liquor (e.g., spirits). or (3) wine they had consumed in the past 7 days. These responses were summed and analysed by alcohol category.
Gut integrity, immune activation and inflammation
At each of the four time-points, subjects completed fasting (> 12 h) blood draws, which were used to obtain measurements of lipid profiles and glucose and insulin levels. Additionally, plasma, serum and peripheral blood mononuclear cells were cryopreserved for measurement of markers of immune activation, systemic inflammation and gut integrity markers as previously described [28, 29] . Soluble markers of monocyte activation (sCD14 and sCD163), the proportion of pro-inflammatory monocytes [CD14+CD16+ and CD14(Dim)CD16(+) monocytes] and systemic inflammation (IL-6, sTNFR-II and VCAM) were measured as previously described. [28] We assessed gut integrity with plasma I-FABP (a systemic marker of gut epithelial cell death), LBP (an indirect marker of bacterial translocation from the gut to the circulation) [29] and zonulin-1 (a marker of intestinal permeability as zonulin is expressed by viable gut epithelial cells to disassemble tight junctions between cells, increasing permeability and macromolecule absorption) [30] . 
Markers of subclinical CVD
At entry, week 48 and week 96, mean-mean common carotid artery intima-media thickness (CCA-IMT) was measured by high-resolution ultrasound. [31] Measurements were taken at three separate angles bilaterally and the average of the six measurements was used for analysis. Coronary artery calcium score (CAC) was quantified offline as previously described from gated, noncontrast coronary calcium scans performed on a 64-slice multidetector computed tomography (CT) scanner. [31] 
Statistical analysis
For this exploratory study, we performed descriptive analyses of all baseline demographics and study variables. We summarized all continuous and categorical variables using mean AE standard deviation (SD) and percentages of certain categories, respectively. We examined the biomarker data distribution graphically and by running frequency analysis, and also performed a ShapiroÀWilk test for normality. Most of the measured biomarker distributions were skewed. Therefore, we applied BoxÀCox transformations to the biomarkers so that skewness of the biomarker data was zero.
To examine our hypothesis that higher dietary intake of total daily fat, and lower polyunsaturated fat:saturated fat ratio and total dietary fibre intake lead to worse markers of gut integrity, which eventually results in increased monocyte activation, inflammation and worse markers of cardiovascular health, we used nonparametric (Spearman) correlation and scatter plots. Based on this correlational analysis, we identified several biomarkers of diet, gut integrity, inflammation and cardiovascular health were significantly associated (P < 0.05). We further studied these associations in a regression framework after controlling for several covariates such as age, sex, race, body mass index (BMI), current CD4 T-cell count, time, and statin treatment assignment (indicator variable). For baseline biomarker analyses we used multiple linear regression models, and for longitudinally measured biomarker analyses we used linear mixed effects (LME) models with random intercept and slope. In the LME model, we assumed that the random intercept and slope follow a multivariate normal distribution with exchangeable varianceÀcovariance structure. We also assumed that the missing data followed a missing at random mechanism. A number of subjects withdrew or were lost to follow-up from the study; however, none of these withdrawals or losses to follow-up were attributable to drug-related adverse events or related to the specific values of our outcome variables that should have been obtained. According to the American Statistical Association statement on P-value, we emphasized the magnitude of the relationship and effect size (nonzero b coefficients) rather than (adjusted) P-values [32] . The analyses were carried out using STATA 14 SE (StataCorp, College Station, TX).
Results
Baseline characteristics
All 147 SATURN-HIV participants were included in this analysis, of whom 118 completed all longitudinal measurements. Demographic and baseline characteristics are displayed in Table 1 . Mean (SD) age was 45 (9.9) years, mean (SD) BMI was 28.1 (6.5), 78% were male, 68% were African American, and 63% smoked at study entry. Mean (SD) current and nadir CD4 T-cell counts were 640 (300) and 200 (146) cells/ll, respectively. Mean (SD) known duration of HIV infection was 12 (6.9) years. All participants were on ART and 85% had HIV-1 RNA < 50 copies/ml. Associations among diet, gut integrity, inflammation and cardiovascular health
Dietary characteristics
We hypothesized that higher dietary intake of total daily fat, higher "bad" carbohydrates (carbohydrate grams - fibre grams), lower polyunsaturated fat:saturated fat ratio, and lower total dietary fibre intake would be associated with worse gut integrity (increased I-FABP and LBP and decreased zonulin). In contrast to our hypothesis, however, we found that the polyunsaturated fat:saturated ratio was significantly correlated (in the unexpected direction) with the gut integrity biomarker I-FABP (Spearman r = 0.252; P = 0.006) and that liquor consumption in the past week correlated with LBP (r = 0.192; P = 0.037; Table 3 ).
Furthermore, the association between I-FABP and the polyunsaturated:saturated fat ratio remained strong at baseline in a multiple linear regression analysis (b = 1.829; P = 0.014) and longitudinally in the linear mixed model analysis (b = 1.254; P = 0.009) after controlling for age, sex, race, BMI, current CD4 T-cell count, time and statin treatment assignment. The gut integrity biomarker LBP and monocyte activation biomarker sCD163 were also statistically significantly correlated (r = 0.224; P = 0.015). After controlling for age, sex, race, BMI, current CD4 T-cell count, time and statin treatment as covariates, baseline LBP was significantly associated with sCD163 in the multiple linear regression analysis (b = 0.020; P = 0.026) and longitudinally measured sCD163 in the LME model (b = 0.019; P = 0.002).
We further hypothesized that alcohol intake would be associated with worse gut integrity and inflammation markers. Indeed, liquor consumption in the past week positively correlated with LBP (r = 0.192; P = 0.037). Over time, alcohol use, particularly liquor use, was associated with gut integrity, monocyte activation and inflammation. After controlling for age, sex, race, BMI, treatment group, CD4 T-cell count and time, beer consumption was associated with sCD14 (b = 0.024; P = 0.002) and liquor consumption was associated with LBP (b = 0.326; P = 0.018), sCD14 (b = 0.031; P < 0.001)) and IL-6 (b = 0.203; P = 0.004; Table 4 ).
With regard to subclinical vascular disease as measured by CAC score or CIMT, we observed mixed associations. For gut integrity markers, LBP was positively correlated Linear mixed models of dietary characteristics over time indicated a significant decline in macronutrients; however, alcohol consumption did not change over time (using generalized estimating equations). with CAC (r = 0.362; P = 0.014) but I-FABP was negatively correlated with CAC (r = À0.292; P = 0.049). The negative association of I-FABP with CAC remained after adjustment in the longitudinal LME model (Table 5) . For inflammation markers, sTNFR-II was positively associated with both CCA-IMT and CAC, but VCAM was associated with CCA-IMT only (all P < 0.05) in cross-sectional analyses. However, the relationship between VCAM and CCA-IMT was not statistically significant after controlling for potential confounders in regression models. In longitudinal LME models, sTNFR-II was statistically significantly associated with both CCA-IMT (b = 0.004; P = 0.016) and CAC (b = 0.053; P = 0.032) scores after controlling for the covariates. Alcohol use was not associated with subclinical CVD in any of our analyses (all P > 0.05).
Discussion
In our sample of HIV-infected adults who were on stable ART in the USA, we found that their dietary intake met caloric needs but was comprised mostly of carbohydrates and fats. This macronutrient composition declined over time with a corresponding decrease in kcal. Alcohol consumption was stable over time. We did not find evidence to support the hypothesis that higher dietary intake of fat would be related to worse gut integrity, increased inflammation, or markers of subclinical CVD. These are among the first data describing the longitudinal dietary composition of HIV-infected adults in a well-resourced country in the contemporary ART era. Diet patterns indicate that, on average, our participants consumed within the recommended ranges of calories for their age. The macronutrient composition of their diet, however, did not meet recommendations. Specifically, the average carbohydrate consumption was almost twice recommended daily intake, while protein consumption was only a third of the recommended level. This is concerning, as substantial evidence in the general population suggests that low-carbohydrate and high-protein diets favourably impact body mass and improve cardiovascular health. [34, 35] After initiating ART, approximately onethird to one-half of HIV-infected adults are overweight or obese, [36, 37] and obesity is more prevalent in HIV-infected women than in HIV-infected men. [38] Our data, when examined in conjunction with this evidence, suggest that structured, evidence-based interventions designed to lower carbohydrate and increase protein consumption may help to mitigate the rising obesity epidemic in HIV-infected adults.
Alcohol use is common among HIV-infected adults and our evidence suggests that liquor use is associated with increased microbial translocation and subsequent immune Table 4 Examining the associations of alcohol use with gut integrity and inflammation using linear mixed models activation and inflammation. Alcohol is known to enhance LPS translocation acutely and over time. [18] This can occur by inducing nitric oxide synthase and Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-jB) signalling, which can result in differential expression of tight junction proteins, impairment of gut integrity indirectly through inflammation, or an increase in the LPS-producing gram-negative bacterial microflora. [18] Heavy alcohol use in HIV-infected patients has been found to accelerate HIV disease progression, [39] and one study found an association between unhealthy alcohol intake and higher sCD14 in untreated HIV-infected subjects in Uganda; [40] however, to the best of our knowledge, no one has previously demonstrated associations of alcohol use with such a broad range of markers of microbial translocation, immune activation, and inflammation in treated HIV-infected adults. This evidence is consistent with the hypothesis that alcohol, in particular liquor, use increases translocation of LPS, which interacts with LBP, resulting in increased immune activation and inflammation, perhaps resulting in HIV disease progression. In contrast with a recent review by Kelso et al., [41] we did not find evidence that alcohol use was associated with two common markers of subclinical CVD; however, it is plausible that alcohol use may be related to CVD risk (both positively and negatively) in HIV-infected individuals through other pathways (i.e. plaque vulnerability and platelet effects). Contrary to our hypotheses, other than for alcohol we did not find consistent evidence that dietary intake was associated with markers of gut integrity, inflammation and markers of cardiovascular health. This was surprising and may be explained by our measure of dietary intake. Our dietary interview is a widely used, valid and reliable measure of dietary intake. [27] Yet, like many self-report measures, it is subject to social desirability and memory biases leading participants to overestimate healthy behaviours. To overcome this, nutrition experts recommend collecting dietary intake over the previous 24 h on multiple, nonconsecutive days to accurately reflect the usual dietary intake of an individual. [42, 43] Our findings may also be explained by the fact that, given the mean CD4 T-cell nadir of 200 cells/ll, our participants may represent a population of HIV-infected adults with less exposure to severe immunodeficiency over the course of their HIV disease. [30] Hunt et al. reported that the relationship between gut mucosal damage and microbial translocation was a less significant driver of mortality in treated HIV-infected adults with historically less immunodeficiency. [30] It is possible that our subjects experienced less gut epithelial cell death over the course of their HIV infection, attenuating any relationship between diet, gut integrity and inflammation. Additionally, we have also previously shown that rosuvastatin reduces the levels of I-FABP, which may also have attenuated any relationship between diet, gut integrity and inflammation. [28] Taken together, these findings suggest that different macronutrients may have a differential impact on gut integrity, which may be modified by immunodeficiency and medications, and future research should continue to examine this relationship further.
In addition to the finding that the patients had a highcarbohydrate, low-protein diet, several other dietary characteristics are noteworthy. There was a trend towards high fat and low fibre consumption, indicating that perhaps diet interventions should also target these macronutrients. These dramatic deviations from recommended dietary composition also suggest that an annual dietary assessment may be beneficial in developing targeted, personalized dietary interventions for individual HIVinfected adults. Though it may be logistically challenging, our data suggest that improving nutrition is an untapped area in HIV primary care. Additionally, large HIVinfected cohort studies (e.g. North American AIDS Cohort Collaboration on Research and Design or NA-ACCORD) should consider adding a regular, valid dietary assessment at their subjects' annual visit. As this population experiences increased chronic comorbidities often linked to diet (e.g. diabetes, bone disease and CVD) [44] , these rich data may help us better understand the unique aspects of HIV infection that contribute to this increased prevalence.
Limitations
This study has several limitations. First, the study was conducted at a single US site in a predominately male, African-American sample that had heightened inflammation. Although this represents the emerging HIV epidemic in the USA, our findings pertaining to dietary consumption may not be generalizable beyond this population. Secondly, we assessed gut integrity using distal serum markers. To better analyse the relationship between diet, gut integrity, inflammation and cardiovascular health, a proximal measure of the gut microbiome (fecal DNA sampling) [45] could be used. Although this measure may be limited by subject acceptability, it is likely to be a more direct measure of this pathway. Thirdly, the parent study design required that we enrolled a sample of patients with no history of coronary disease, diabetes or active infectious or inflammatory conditions. The dietary patterns observed in this, perhaps healthier sample may not be reflective of the general population with HIV infection. Finally, it is possible that we have unmeasured variables, such as poverty and food security, that may help us better understand the dietary patterns in this populations. Future studies investigating the natural dietary habits of HIV-infected adults should examine the influence of these variables.
In conclusion, we have presented novel data detailing the generally poor dietary intake of HIV-infected adults in a well-resourced setting. Alcohol use was consistently associated with poor gut integrity, immune activation and inflammation, suggesting an urgent need to reduce alcohol use in this population. This evidence can be used as a foundation for developing evidence-based, targeted individual and structural interventions to help improve dietary intake and reduce alcohol consumption in this population.
